Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Mefuparib hydrochloride induces apoptosis and possesses prominent anticancer activity in vitro and in vivo. Mefuparib hydrochloride (MPH) is an orally active, substrate-competitive and selective PARP1/2 inhibitor with IC50s of 3.2 nM and 1.9 nM, respectively.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | 10-14 weeks | $ 668.00 | |
50 mg | 10-14 weeks | $ 868.00 | |
100 mg | 10-14 weeks | $ 1,310.00 |
Description | Mefuparib hydrochloride induces apoptosis and possesses prominent anticancer activity in vitro and in vivo. Mefuparib hydrochloride (MPH) is an orally active, substrate-competitive and selective PARP1/2 inhibitor with IC50s of 3.2 nM and 1.9 nM, respectively. |
Targets&IC50 | TNKS1:1.6 μM, PARP2:1.9 nM, PARP1:3.2 nM, TNKS2:1.3 μM |
In vitro | Mefuparib hydrochloride (1-10 μM; 24 hours) causes the accumulation of DSB marked by the increased levels of γH2AX in the MDA-MB-436 (BRCA1?/?) cells in a concentration-dependent manner[1]. Mefuparib hydrochloride exerts potent in vitro proliferation-inhibitory effects on cancer cells derived from different human tissues with an average IC50 of 2.16 μM (0.12 μM~3.64 μM)[1]. Mefuparib hydrochloride inhibits PARP3 (IC50>10 μM), PARP6 (IC50>10 μM), TNKS1 (IC50=1.6 μM), TNKS2 (IC50=1.3 μM)[1].Mefuparib hydrochloride (1-10 μM;?48 hours) causes cell apoptosis[1].??Mefuparib hydrochloride (MPH;?1-10 μM;?24 hours) causes V-C8 cells into typical G2/M arrest[1]. |
In vivo | Mefuparib hydrochloride (10, 20, 40 mg/kg; oral) has a T1/2 of 1.07-1.3 hours and a C max of 116-725 ng/mL for SD rats[1]. Mefuparib hydrochloride (5, 10, 20 mg/kg; oral) has a T1/2 of 2.16-2.7 hours and a C max of 114-608 ng/mL for cynomolgus monkeys[1].?Mefuparib hydrochloride (MPH;?40-160 mg/kg;?orally;?once every other day;?for 21 days) displays dose- and time-dependent killing on V-C8 xenografts accompanied by complete disappearance of some xenografts, especially in the high-dose group[1].??Mefuparib hydrochloride (160 mg/kg;?orally;?once every other day;?for 21 days) inhibits the growth of the BR-05-0028 breast patient-derived xenograft (PDX) without obvious loss of body weight[1]. |
Synonyms | MPH |
Molecular Weight | 334.77 |
Formula | C17H16ClFN2O2 |
CAS No. | 1449746-00-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Mefuparib hydrochloride 1449746-00-2 Chromatin/Epigenetic DNA Damage/DNA Repair PARP MPH Mefuparib Hydrochloride inhibitor inhibit